Drug Profile
Research programme: AntiPARP compounds - Octamer
Alternative Names: AntiPARP 1; AntiPARP 2; CPH-102; I-NO2BALatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Octamer
- Class
- Mechanism of Action Poly(ADP-ribose) polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; HIV infections; Inflammation
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in HIV-infections in USA (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in USA (PO)